Acupuncture
Aleksey Radchenko, Certified specialist in acupuncture
Homeopathy
Svetlana Laputjko, Specialist in homeopathy
Psychotherapy
Psychotherapist Alexander Moshkin
Atmest smēķēšanu
Caurdurt ausis
  about us specialists price-list contact us   lv ru en  
DiagnosticsTreatmentBemer-Therapy


ROS ROS
                           


   news News of medicine.
 
 

Increased Risk of Harm from Cannabis

 
 

25/02/2019

Cannabis resin and herbal cannabis have significantly increased in potency and in price, according to the first study to investigate changes in cannabis across Europe.

The study, published today (Sunday 30 December) in the journal Addiction by researchers from the University of Bath and King's College London, draws on data collected from across 28 EU Member states, as well as Norway and Turkey by the European Monitoring Centre for Drugs and Drug Addiction.

The findings show that for herbal cannabis, concentrations of delta-9-tetrahydrocannabinol ('THC' -- the main psychoactive constituent of cannabis) increased by a similar amount each year, from 5% in 2006 to 10% in 2016. For cannabis resin (or hash), THC concentrations were relatively stable from 2006 to 2011 (from 8% to 10%) but then increased rapidly from 2011 to 2016 (from 10% to 17%). The price of cannabis resin also increased, but to a lesser extent than for herbal cannabis.

Lead author Dr Tom Freeman from the Addiction and Mental Health Group within the Department of Psychology at the University of Bath, said: "These findings show that cannabis resin has changed rapidly across Europe, resulting in a more potent and better value product."

Unlike herbal cannabis, cannabis resin typically contains cannabidiol (CBD) in addition to THC. CBD has recently attracted considerable interest due to its potential to treat several medical conditions including childhood epilepsy syndromes, psychosis and anxiety. When present in cannabis, CBD may offset some of the harmful effects of THC such as paranoia and memory impairment.

Cannabis containing higher levels of THC and / or lower levels of CBD has been linked to greater long-term harms such as the development of cannabis dependence, and an increased risk of psychotic illness.

New resin production techniques in Morocco and Europe have increased levels of THC, but not CBD. Dr Freeman added: "CBD has the potential to make cannabis safer, without limiting the positive effects users seek. What we are seeing in Europe is an increase in THC and either stable or decreasing levels of CBD, potentially making cannabis more harmful.

These changes in the illicit market are largely hidden from scientific investigation and are difficult to target by policy-makers. An alternative option could be to attempt to control THC and CBD content through regulation." It is estimated that 24 million people (or 7.2%) of European adults used cannabis in the last year. Across the globe 192 million people use the drug in a variety of markets, ranging from heavily sanctioned prohibition to commercialised legal sale.

Cannabis policies are rapidly changing across the globe. Recreational use is now legalised in Canada and several US states, and medical use is permitted in many more countries, including very recently in the UK.

 
   
 

sciencedaily.com

 
 
 
 
 
E-APTIEKA  THAT You searched, possibly HERE >>> E-Shop of Health
 
   

Godži ogas 280/50 500g

18.50 €

Godži ogas augušas Ningxia provincē – saulainā apvidū augstu kalnos.
Ogas audzētas atbilstoši Eiropas Savienības prasībām pret pesticīdu daudzumu pārtikas precēm un tās ir pārbaudītas un sertificētas ĶTR Fitosanitārajā inspekcijā.
Ogas kaltētas svaigā gaisā saules gaismā, šķirotas divas reizes un lietojamas uzturā, kam ir atbilstošs sertifikāts. Visvienkāršākais ogu lietošanas veids ir to lietošana sausā veidā.
Lietošana: diennakts norma – aptuveni 10-30 grami. Bērniem līdz 10 gadiem- 1 tējkarote, bērniem pēc 10 gadiem- 1ēdamkarote no rīta.
Tās var lietot pievienojot jogurtiem, musli, salātiem, gatavojot garnējumus un mērces. No tām iespējams gatavot dziednieciskās tinktūras un uzlējumus.
Iepakojumā: 500g.

   

Glikometrs ACCU-CHEK ACTIVE

19.70 €

Glikometrs ACCU-CHEK ACTIVE ir portatīvs teststrēmeļu analizators glikozes noteikšanai kapilārajās asinīs.
Iepakojumā: analizators Accu-Chek Active, autolancete, 10 vienreizējas lietošanas lancetes un 10 teststrēmeles auduma maciņā, lietošanas instrukcija.
Ražotājs: Roche, Vācija.

 

 

trauma or stroke    neuroses    psychiatrist    Psychoanalysis    children and adolescents    teenagers    Svetlana Laputko    Acupuncture    Aleksey Radchenko    Igor Shelegov   intervertebral disks    Acupuncture   Alexander Moshkin    Svetlana Laputko    Aleksey Radchenko    Igor Shelegov    Acupuncture    trauma or stroke    neuroses   Alexander Moshkin    intervertebral disks    neuroses    sonography    Psychoanalysis    Svetlana Laputko    Aleksey Radchenko    children and adolescents    teenagers    ultrasonography   Acupuncture    Acupuncture    Igor Shelegov   intervertebral disks    Acupuncture    psychiatrist    trauma or stroke    intervertebral disks    neuroses   Alexander Moshkin    neuroses    Psychoanalysis    Svetlana Laputko    sonography    ultrasonography    children and adolescents    Aleksey Radchenko   Acupuncture    psychiatrist    teenagers    Igor Shelegov    Acupuncture    intervertebral disks    Acupuncture    neuroses   Alexander Moshkin    sonography   intervertebral disks    trauma or stroke    Svetlana Laputko    ultrasonography   Acupuncture    neuroses    Aleksey Radchenko    Igor Shelegov    Psychoanalysis    psychiatrist    Acupuncture    children and adolescents   Alexander Moshkin    Svetlana Laputko   

All rights are protected. © 'ROS' Ltd, 2008
PULS.LV Professional statistical system       Europuls.eu - Catalog of the European Internet resources      Яндекс.Метрика Auraj studio карта сайта